131 related articles for article (PubMed ID: 26906105)
1. Is there a role for urinary podocyte excretion assessment in lupus nephritis?
Mansur JB; Sabino AR; Nishida SK; Kirsztajn GM
Ren Fail; 2016; 38(4):643-7. PubMed ID: 26906105
[TBL] [Abstract][Full Text] [Related]
2. Detection of podocyturia in patients with lupus nephritis.
Sabino AR; Teixeira Vde P; Nishida SK; Sass N; Mansur JB; Kirsztajn GM
J Bras Nefrol; 2013; 35(4):252-8. PubMed ID: 24402104
[TBL] [Abstract][Full Text] [Related]
3. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
5. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients.
Trimarchi H; Canzonieri R; Schiel A; Politei J; Stern A; Andrews J; Paulero M; Rengel T; Aráoz A; Forrester M; Lombi F; Pomeranz V; Iriarte R; Young P; Muryan A; Zotta E
J Nephrol; 2016 Dec; 29(6):791-797. PubMed ID: 26842625
[TBL] [Abstract][Full Text] [Related]
6. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
[TBL] [Abstract][Full Text] [Related]
7. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
8. Urinary podocytes for the assessment of disease activity in lupus nephritis.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
Am J Med Sci; 2000 Aug; 320(2):112-6. PubMed ID: 10981486
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
10. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
Gupta R; Yadav A; Misra R; Aggarwal A
Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
[TBL] [Abstract][Full Text] [Related]
11. Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare.
Ayoub I; Birmingham D; Rovin B; Hebert L
Curr Rheumatol Rep; 2019 Feb; 21(4):12. PubMed ID: 30810824
[TBL] [Abstract][Full Text] [Related]
12. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
13. Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis.
Matar HE; Peterson P; Sangle S; D'Cruz DP
Lupus; 2012 Jul; 21(8):836-9. PubMed ID: 22331194
[TBL] [Abstract][Full Text] [Related]
14. Complement degradation product C3d in urine: marker of lupus nephritis.
Negi VS; Aggarwal A; Dayal R; Naik S; Misra R
J Rheumatol; 2000 Feb; 27(2):380-3. PubMed ID: 10685801
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.
Yang X; Gao Y; Wang H; Zhao X; Gong X; Wang Q; Zhang X
J Rheumatol; 2014 Sep; 41(9):1793-800. PubMed ID: 25086075
[TBL] [Abstract][Full Text] [Related]
16. Increased excretion of urinary podocytes in lupus nephritis.
Bollain-Y-Goytia JJ; González-Castañeda M; Torres-Del-Muro F; Daza-Benitez L; Zapata-Benavides P; Rodríguez-Padilla C; Avalos-Díaz E; Herrera-Esparza R
Indian J Nephrol; 2011 Jul; 21(3):166-71. PubMed ID: 21886975
[TBL] [Abstract][Full Text] [Related]
17. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
[TBL] [Abstract][Full Text] [Related]
18. Assessment of lupus nephritis activity using urinary retinol-binding protein.
Sesso R; Rettori R; Nishida S; Sato E; Ajzen H; Pereira AB
Nephrol Dial Transplant; 1994; 9(4):367-71. PubMed ID: 8084448
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
20. The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis.
Wang FM; Yu F; Tan Y; Liu G; Zhao MH
Lupus; 2014 Jun; 23(7):655-64. PubMed ID: 24536044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
